Bococizumab is a remarkable anti-PCSK9 antibody specifically developed to combat hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a key regulator of cholesterol amounts. By inhibiting the https://kianaifnh863553.wikicorrespondence.com/6552840/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia